GlassScriptPhysician profile
Michael P Houston
NPI 1962516682
$4,187.86
in general payments reported to CMS, 2019-2025
22 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $524 · 2020: $739 · 2021: $1,340 · 2022: $497 · 2023: $652 · 2024: $436.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,087.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,087.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $881.75 | 2019-2024 | Ofev |
| Glaxosmithkline, LLC. | $621.31 | 2019-2024 | Trelegy Ellipta |
| Insmed, INC. | $596.74 | 2019-2024 | Arikayce |
| Astrazeneca Pharmaceuticals LP | $517.27 | 2019-2024 | Fasenra, Tezspire |
| Electromed, INC. | $400.71 | 2021-2024 | Smartvest |
| Jazz Pharmaceuticals INC. | $196.93 | 2019-2023 | Xywav |
| Mylan Specialty L.P. | $176.25 | 2019-2023 | Yupelri |
| Novartis Pharmaceuticals Corporation | $115.39 | 2019 | |
| Sunovion Pharmaceuticals INC. | $110.06 | 2019-2020 | |
| Genzyme Corporation | $97.76 | 2019-2023 | |
| Regeneron Healthcare Solutions, INC. | $93.78 | 2021-2023 | Dupixent |
| Genentech USA, INC. | $77.09 | 2020-2022 | |
| Philips North America LLC | $64.60 | 2019-2021 | |
| Amgen INC. | $49.93 | 2023 | Tezspire |
| Paratek Pharmaceuticals, INC. | $42.88 | 2023 | Nuzyra |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inogen, INC. | $35.07 | 2022-2024 | |
| Teva Pharmaceuticals USA, INC. | $27.30 | 2021 | |
| Actelion Pharmaceuticals US, INC. | $21.99 | 2023 | Opsumit |
| Janssen Pharmaceuticals, INC | $16.97 | 2021 | |
| Pulmonx Corporation | $15.77 | 2021 | |
| 3b Medical, INC. | $14.61 | 2023 | Luna |
| Circassia INC. | $13.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Houston listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.